PMC Insider Trading Activity and SEC Form 4 Filings
PMC insider trading summary
No open-market insider purchases or sales of PharMerica CORP (PMC) have been reported on SEC Form 4 in the past 12 months.
Latest PMC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 7, 2017 | Gregory S Weishar | Chief Executive Officer | Sell | $44K (1,500 @ $29.25) |
| Dec 7, 2017 | Gregory S Weishar | Chief Executive Officer | Sell | $15.2M (519,589 @ $29.25) |
| Dec 2, 2015 | Robert A McKay | SVP Purchasing,Trade Relations | Sell | $103K (2,993 @ $34.42) |
| Nov 11, 2015 | Mark Lindemoen | SVP Sales and Client Services | Sell | $132K (3,790 @ $34.71) |
| Jun 16, 2015 | Robert A McKay | SVP Purchasing,Trade Relations | Sell | $229K (7,000 @ $32.75) |
| Jun 3, 2015 | Gregory S Weishar | Chief Executive Officer | Sell | $2.6M (79,344 @ $32.50) |
| Jun 3, 2015 | Gregory S Weishar | Chief Executive Officer | Sell | $228K (7,000 @ $32.62) |
| Jun 3, 2015 | Gregory S Weishar | Chief Executive Officer | Sell | $70K (2,145 @ $32.75) |
| Jun 2, 2015 | Gregory S Weishar | Chief Executive Officer | Sell | $521K (15,661 @ $33.29) |
| Jun 1, 2015 | Mark Lindemoen | SVP Sales and Client Services | Sell | $150K (4,500 @ $33.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.